Hepatitis

Hepatitis A virus (HAV) is one of the most common causes of liver inflammation. When first infected with HAV, your immune system produces IgM antibodies, which appear in your blood 5 to 10 days before symptoms appear. They can stay in your blood for about six months after infection, with IgG antibodies remaining for life.
Hepatitis A virus is one of the most common causes of liver inflammation. Your immune system makes antibodies when you are first infected with HAV. IgM Antibodies often begin to appear in the blood 5 to 10 days before symptoms appear. They can stay in your blood for about six months after the infection. Some antibodies called IgG can last in your blood for life.
Hepatitis A is commonly spread by eating or drinking contaminated food or water. This may happen if an infected person doesn't wash their hands after using the bathroom. Most people recover from hepatitis A without lasting liver damage. This test detects the presence of HAV antibodies, which indicate prior or acute infection with, or immunization to, the hepatitis A virus.
Hepatitis B Virus (HBV) is one of the most common causes of liver inflammation. Your immune system makes IgM antibodies against HBV during the active stage several weeks after you are first infected. The IgG variant is produced later, and you will likely have a positive HBcAb IgG test for the rest of your life. People with the hepatitis B vaccine will not have these antibodies in their blood.
The Hepatitis B virus (HBV) is a common cause of liver inflammation. Your immune system makes IgM antibodies against HBV that appear in your blood several weeks after infection. People with the hepatitis B vaccine will not have this antibody in their blood. The test determines whether you are actively infected with the hepatitis B virus (HBV).
The quantitative test of hepatitis B core antibody level distinguishes cases of hepatitis antibodies from vaccination with those with a history of cured acute hepatitis B. This test can also be used with other hepatitis immunological indicators to evaluate treatment effectiveness in hepatitis B patients.
The hepatitis B virus (HBV) is one of the major causes of liver inflammation. The hepatitis B e antigen (HBeAg) appears after an HBV infection. Usually, HBeAg indicates much higher rates of viral replication and enhanced infectivity. However, variants of the hepatitis B virus do not produce the 'e' antigen, so this rule does not always hold. The HBeAg may be cleared, and antibodies to the 'e' antigen (anti-HBe) will arise immediately afterward, suggesting a dramatic decline in viral replication.
This is a viral protein made by the hepatitis B virus that is released from infected liver cells into the blood. A positive HBeAg indicates high virus levels in the blood, with the person considered infectious. A negative result indicates very low to no virus in the blood, and the person is considered less infectious; sometimes, this can indicate a person has a mutant hepatitis B virus.
Hepatitis B is a liver inflammation caused by the type B virus and is one of the most common causes of cirrhosis in Viet Nam. HBsAb is a protein your immune system produces to fight against the hepatitis B virus. The presence of anti-HBs is generally interpreted as indicating recovery and immunity from hepatitis B virus infection. Anti-HBs also develop in a person successfully vaccinated against hepatitis B.
Hepatitis B is a liver inflammation caused by the type B virus and is one of the most common causes of cirrhosis in Viet Nam. Hepatitis B surface antigen (HBsAg) is a protein that appears in the blood when you have a hepatitis B infection.
Hepatitis B is a liver inflammation caused by the type B virus and is one of the most common causes of cirrhosis in Viet Nam. Hepatitis B surface antigen (HBsAg) is a protein that appears in the blood when you have a hepatitis B infection.
HBV-DNA or hepatitis B virus DNA is a measure of the viral load of the hepatitis B virus in the blood. A high HBV-DNA level indicates that the virus is multiplying in the individual’s body and the person is contagious. The test is most often used to monitor the efficacy of antiviral therapy in individuals with chronic HBV infection.
HBV-DNA or hepatitis B virus DNA is a measure of the viral load of the hepatitis B virus in the blood. A high HBV-DNA level indicates that the virus is multiplying in the individual’s body and the person is contagious. The test is most often used to monitor the efficacy of antiviral therapy in individuals with chronic HBV infection.
loading.svg